Hikma Pharmaceuticals PLC ADR (HKMPY)

OTC Markets
Currency in USD
56.2
0.0(0.00%)
Closed·
HKMPY Scorecard
Full Analysis
Has raised its dividend for 8 consecutive years
HKMPY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
56.256.2
52 wk Range
46.059.3
Key Statistics
Edit
Prev. Close
56.9
Open
56.2
Day's Range
56.2-56.2
52 wk Range
46-59.3
Volume
251
Average Vol. (3m)
828
1-Year Change
10.85%
Book Value / Share
10.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HKMPY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Hikma Pharmaceuticals PLC ADR News & Analysis

Show more

Hikma Pharmaceuticals PLC ADR Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Employees
9500

Compare HKMPY to Peers and Sector

Metrics to compare
HKMPY
Peers
Sector
Relationship
P/E Ratio
16.8x12.9x−0.5x
PEG Ratio
0.190.080.00
Price / Book
2.6x1.9x2.6x
Price / LTM Sales
1.9x1.9x3.0x
Upside (Analyst Target)
-3.4%51.9%
Fair Value Upside
Unlock17.6%8.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.62%
Dividend Yield
2.78%
Industry Median 1.73%
Annualized Payout
1.56
Paid semi-annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Mar 19, 2025
EPS / Forecast
0.60 / --
Revenue / Forecast
1.56B / --
EPS Revisions
Last 90 days

HKMPY Income Statement

FAQ

What Is the Hikma Pharma ADR (HKMPY) Stock Price Today?

The Hikma Pharma ADR stock price today is 56.20

What Stock Exchange Does Hikma Pharma ADR Trade On?

Hikma Pharma ADR is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Hikma Pharma ADR?

The stock symbol for Hikma Pharma ADR is "HKMPY."

Does Hikma Pharma ADR Pay Dividends? What’s The Current Dividend Yield?

The Hikma Pharma ADR dividend yield is 2.78%.

What Is the Hikma Pharma ADR Market Cap?

As of today, Hikma Pharma ADR market cap is 6.10B.

What Is Hikma Pharma ADR's Earnings Per Share (TTM)?

The Hikma Pharma ADR EPS (TTM) is 1.62.

From a Technical Analysis Perspective, Is HKMPY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hikma Pharma ADR Stock Split?

Hikma Pharma ADR has split 0 times.

How Many Employees Does Hikma Pharma ADR Have?

Hikma Pharma ADR has 9500 employees.

What is the current trading status of Hikma Pharma ADR (HKMPY)?

As of Jun 20, 2025, Hikma Pharma ADR (HKMPY) is trading at a price of 56.20, with a previous close of 56.90. The stock has fluctuated within a day range of 56.20 to 56.20, while its 52-week range spans from 46.00 to 59.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.